Abstract
AbstractBackgroundDespite immense progress in artificial intelligence (AI) models, there has been limited deployment in healthcare environments. The gap between potential and actual AI applications is likely due to the lack of translatability between controlled research environments (where these models are developed) and clinical environments for which the AI tools are ultimately intended.ObjectiveWe have previously developed the Translational Evaluation of Healthcare AI (TEHAI) framework to assess the translational value of AI models and to support successful transition to healthcare environments. In this study, we apply the TEHAI to COVID-19 literature in order to assess how well translational topics are covered.MethodsA systematic literature search for COVID-AI studies published between December 2019-2020 resulted in 3,830 records. A subset of 102 papers that passed inclusion criteria were sampled for full review. Nine reviewers assessed the papers for translational value and collected descriptive data (each study was assessed by two reviewers). Evaluation scores and extracted data were compared by a third reviewer for resolution of discrepancies. The review process was conducted on the Covidence software platform.ResultsWe observed a significant trend for studies to attain high scores for technical capability but low scores for the areas essential for clinical translatability. Specific questions regarding external model validation, safety, non-maleficence and service adoption received failed scores in most studies.ConclusionsUsing TEHAI, we identified notable gaps in how well translational topics of AI models are covered in the COVID-19 clinical sphere. These gaps in areas crucial for clinical translatability could, and should, be considered already at the model development stage to increase translatability into real COVID-19 healthcare environments.
Publisher
Cold Spring Harbor Laboratory
Reference28 articles.
1. Artificial Intelligence: Promise, Pitfalls, and Perspective;JAMA,2020
2. Artificial intelligence-enabled healthcare delivery;J R Soc Med,2019
3. United States Government Accountability Office. Artificial Intelligence in Health Care: Benefits and Challenges of Technologies to Augment Patient Care | U.S. GAO. Artif Intell Health Care Benefits Chall Technol Augment Patient Care. 2020. Available from: https://www.gao.gov/products/gao-21-7sp [accessed Jul 13,2022]
4. Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare;Npj Digit Med,2022
5. Evaluating Artificial Intelligence Applications in Clinical Settings;JAMA Netw Open United States,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Çeviribiliminin Yapay Zeka (YZ) ile Geliştirilmesi: Zorluklar, İmkânlar ve Öneriler;Karamanoğlu Mehmetbey Üniversitesi Uluslararası Filoloji ve Çeviribilim Dergisi;2023-12-30